Adial Pharmaceuticals, Inc. Stock Repurchase Program, Remaining Number of Shares Authorized to be Repurchased
Adial Pharmaceuticals, Inc. (ADIL) had Stock Repurchase Program, Remaining Number of Shares Authorized to be Repurchased of 13.34 thousand shares as of 2023-12-31, per its 10-K filed 2024-04-01.
Discontinued › Notes › Equity
us-gaap:StockRepurchaseProgramRemainingNumberOfSharesAuthorizedToBeRepurchased · last filed 2024-04-01
- 2023-12-31: Stock Repurchase Program, Remaining Number of Shares Authorized to be Repurchased 13.34K shares.
| Period end | Stock Repurchase Program, Remaining Number of Shares Authorized to be Repurchased |
|---|---|
| 2023-12-31 | 13.34K shares 10-K · filed 2024-04-01 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B | |
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Moleculin Biotech, Inc. (MBRX) | United States | $0.011B | |
| MetaVia Inc. (MTVA) | United States | $0.011B | -0.65 |